CYCN vs NKE · $8.6M cap vs P/E 35, rev $46.40B
Cyclerion Therapeutics Inc (CYCN) versus Nike Inc (NKE) — a side-by-side from cached financials, not a winner call.
Cyclerion Therapeutics Inc (CYCN) is a biotechnology company listed on US.
Nike Inc (NKE) is a footwear & accessories company listed on US. It is led by Elliott J. Hill.
Latest reported CYCN revenue for 2026-06-30 was $0. Net income was -$4.9M. CYCN currently screens at market cap $8.6M.
Latest reported NKE revenue for 2026-05-31 was $46.40B. Net income was $3.11B. NKE currently screens at market cap $110.14B and trailing P/E 34.6.
CYCN currently screens at market cap $8.6M. NKE currently screens at market cap $110.14B and trailing P/E 34.6.
Not investment advice. Open the CYCN and NKE stock pages for the full models.
Not investment advice.